a62ebe74239638e0b49f015e8a54d231 *DESCRIPTION
09bd792db81cb9d024e928235e1edb9f *NAMESPACE
92de479b78995106c1d6ff82aaeb2418 *NEWS.md
72103f910f2eb3c97a692aeac68f1e23 *R/data.R
5ef179617637e64a19050313d80a695d *R/get_terms.R
3655d6b661116181ccf021a07f39b336 *R/pharmaversesdtm-package.R
e9251f8a62d5ca564ec1622985569aa1 *README.md
51e4a5324d7f000735ba56973897cd19 *data/ae.rda
49301a8b4cb018ef75c59f6113f83e6f *data/ae_ophtha.rda
4f6ecb06263d90c803cfb3c995cc9471 *data/cm.rda
8a0fe85e1e1cb9212fbe490d7b518824 *data/dm.rda
038064e2fc108c895f4f9b6d2b8e701c *data/ds.rda
107231afb42cb068cafc79b7b3e041a0 *data/eg.rda
8ccd71d84b8ab4da4c779b2ea2d4bdf8 *data/ex.rda
7205d85d39b51b70b7b269e6609b5f6e *data/ex_ophtha.rda
7bd2f960d60f2d4a692d0b21e144e003 *data/lb.rda
c5519dffcd37d7c48f8c969bb48aee64 *data/mh.rda
feb7ca0c62d276e28bd3b7c64419d61b *data/oe_ophtha.rda
5db34d560474f668e537dc5ba316745b *data/pc.rda
b38ee04354b3366f6a0935c1a5dbf4b0 *data/pp.rda
8509579bd14f82fdf1e54a34d1328cf5 *data/qs_ophtha.rda
846c78199fa44234ee3a8001bef26dac *data/rs_onco.rda
85a5273bbb7b0a404c1f3122cae57c95 *data/rs_onco_recist.rda
0efb82bd48b85304c160bd273c5f4b2d *data/sc_ophtha.rda
9adbecdab92a26489a080f9642b44186 *data/sdg_db.rda
7a26cdd62c4d3ded9df83823860c4a9f *data/smq_db.rda
818b09fc217eaa30eb62374497f115b1 *data/suppae.rda
606215775cd85d67aaf2b9bb2cd24dc1 *data/suppdm.rda
db1e62966d0044b7de222a33b3ec9d82 *data/suppds.rda
a1fe3d7b8a0dc0d79a9434dd1bbbd5eb *data/supptr_onco.rda
068d1ab8d562b88f3efaac168b836a45 *data/sv.rda
6c99383bc5006bc287d6ac3ccbeef47e *data/tr_onco.rda
0a903bc51993b02621dd7d121ca7cd13 *data/tr_onco_recist.rda
fcccf1e2bf0db2959219dd35459014d4 *data/ts.rda
624b650e4f78af751af89fbcefc76e63 *data/tu_onco.rda
945251a0b8fdde889242410e0886ecd3 *data/tu_onco_recist.rda
d5b75ef00639168b883ec4124242c59a *data/vs.rda
88ef555e5973f374864fe318bda10c3f *inst/WORDLIST
0ff186ae44197e8f117c145225507da6 *man/ae.Rd
dc60956ac09a9c89995a352c01429a73 *man/ae_ophtha.Rd
44ed2c9e81fb4de1d4ab47b143daded4 *man/cm.Rd
90f79d5eb9455ccabe215dd719666793 *man/dm.Rd
5ed7cd323f9c9869180a8b7df954f85b *man/ds.Rd
382ecdc6a9f59dcafbfb58af0ab8ce9a *man/eg.Rd
1591eb1ac450d0aa0b6a89a75855338f *man/ex.Rd
ebd5f1550ff37c9ea809812d069a6f9e *man/ex_ophtha.Rd
4d9053e699fd19f75ff7f05a98aab6b4 *man/figures/logo.png
2677502b464837f19ce003182ba168c1 *man/get_terms.Rd
c02f225ace1739d1ad788f938844a1d4 *man/lb.Rd
ce1e1293a104b38dcdef3dd49f72ba72 *man/mh.Rd
7085b2faf1b77b4bee6a52bff19cbb6d *man/oe_ophtha.Rd
a97cd7cb4f182a44f954131a65c87544 *man/pc.Rd
dac1277f6923fe09c778709742f1fcac *man/pharmaversesdtm-package.Rd
eafab896fe2fc863dc66e55983005500 *man/pp.Rd
dc6ad6001c256f5f0f2a6656fbc06552 *man/qs_ophtha.Rd
942ff879725c61c492ca6927984824fe *man/roxygen/meta.R
161f0825ea7fbeb63732914c26d9fad4 *man/rs_onco.Rd
9052bab974cfcaaa3203b5981a025ba4 *man/rs_onco_recist.Rd
22bef5ba36b4216088cf80a8441ac21d *man/sc_ophtha.Rd
cd913a0b886459ce8241fda00144f08c *man/sdg_db.Rd
51ec2507176d95d3f171026ac2f65d7f *man/smq_db.Rd
ac42bd0fa03ab0ff93838a8c083e35a6 *man/suppae.Rd
908b635d584ab56971ee696ad77c2016 *man/suppdm.Rd
0de705d4b655c4fb5777dcec19f68b90 *man/suppds.Rd
2de6712291486fa5e0b9fc1d0b12546a *man/supptr_onco.Rd
06caafa6401681d6ca58bfab8784ac30 *man/sv.Rd
8e0fbfe461bd90e8d21d47e1c4c24a36 *man/tr_onco.Rd
e2ff47b9cabaebec62ff2b5d6eef174b *man/tr_onco_recist.Rd
ee4b236072b65f8fa7385c3666c5f90d *man/ts.Rd
190e70e63b7d5b83631cbc189f71a6cd *man/tu_onco.Rd
a3881e0b52099805d4f63a4396809d6d *man/tu_onco_recist.Rd
bbcae557fd03b23fa1c49a77a08f3849 *man/vs.Rd
